Evolab Welcomes Noel Palmer, Ph.D. as Chief Scientist

Tuesday, April 11, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

Award-Winning Cannabis Chemist Joins Evolab to Direct Next Generation Product Development & Analytics

DENVER, April 11, 2017 /PRNewswire/ -- Evolab, the leader in supercritical CO2 extraction and cannabis product development,

today announced that it has appointed Noel Palmer, Ph.D. to the position of Chief Scientist. Dr. Palmer brings more than 15 years of experience as a laboratory chemist with a focus on cannabis analytics and product development to the new position.

"Noel's expertise will elevate our product team, helping poise Evolab to take advantage of enormous new opportunities," said Alex Cahoj, CEO, Evolab. "With his unmatched research and development experience, Noel will help us continue to expand our capabilities and offer additional innovative products that are approachable, reliable and consumer friendly."

A member of the International Cannabinoid Research Society, Dr. Palmer's research, development and analytical experience is world-renowned. In 2014, he was honored as Americans for Safe Access Researcher of the Year. He has authored multiple peer-reviewed publications in noted journals, and is co-inventor of Patent # US20160022627, the first patent issued for a legal cannabis product in the United States. He has co-developed a number of award-winning, industry-first products for companies including Mary's Medicinals and Palliatech.

"With their proprietary processes and technologies, Evolab has already established a reputation as the leader in cannabis extraction, purification and product development," said Palmer. "I'm excited to join this passionate team and help create the next generation of advanced products."

In collaboration with Americans for Safe Access and the American Herbal Products Association, Dr. Palmer was closely involved in drafting the Industry Standards for Laboratory Testing of cannabis, uniquely positioning him to understand the challenges and intricacies of compliant product development in evolving regulatory environments.

All Evolab products are validated internally with an in-house quality control laboratory overseen by Dr. Palmer, as well as by accredited third party labs. Analytical testing is conducted on all raw materials, extracts and final products to ensure every Evolab offering exceeds regulatory standards and consumer expectations.

Evolab products are currently available in dispensaries across Colorado. To find the location nearest you, visit: http://www.evolab.com/store-locator/

About Evolab:Evolab is a pioneer in the use of chromatography and CO2 to produce pharmaceutical-grade cannabis extracts. The company manufactures a full range of cannabis extracts and infused products that are rich in terpenes and pure cannabinoids -- while remaining free of solvents, cutting agents and diluting additives. Evolab is also a provider of cutting-edge technology solutions and production services to other cannabis manufacturers. Founded in 2009 by Alex Cahoj, Evolab is based in Denver, Colorado. Learn more at www.evolab.com

Supporting Resources:

  • Follow @evolabco2 on:
    • Facebook: https://www.facebook.com/evolabco/ 
    • Twitter: https://twitter.com/evolabco2 
    • Instagram: https://www.instagram.com/evolabco2


To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/evolab-welcomes-noel-palmer-phd-as-chief-scientist-300437559.html


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store